These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

715 related items for PubMed ID: 30681791

  • 1. Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic Population.
    Cook-Bolden FE, Weinkle SH, Guenin E, Bhatt V.
    J Drugs Dermatol; 2019 Jan 01; 18(1):32-38. PubMed ID: 30681791
    [Abstract] [Full Text] [Related]

  • 2. Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in an Asian Population.
    Han G, Armstrong AW, Desai SR, Guenin E.
    J Drugs Dermatol; 2019 Sep 01; 18(9):910-916. PubMed ID: 31524347
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and Tolerability of a Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate or Severe Acne Vulgaris in Adult Females.
    Harper JC, Baldwin H, Stein Gold L, Guenin E.
    J Drugs Dermatol; 2019 Nov 01; 18(11):1147-1154. PubMed ID: 31741360
    [Abstract] [Full Text] [Related]

  • 4. Novel Tretinoin 0.05% Lotion for the Once-daily Treatment of Moderate-to-Severe Acne Vulgaris in an Adult and Adolescent Female Population.
    Kircik LH, Baldwin H, Lain E, Guenin E, Harris S, Bhatt V.
    J Drugs Dermatol; 2019 Feb 01; 18(2):178-188. PubMed ID: 30811141
    [Abstract] [Full Text] [Related]

  • 5. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability.
    Stein Gold L, Pariser DM, Guenin E.
    J Drugs Dermatol; 2019 Dec 01; 18(12):1218-1225. PubMed ID: 31860209
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Novel tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris in a preadolescent population.
    Eichenfield LF, Sugarman JL, Guenin E, Harris S, Bhatt V.
    Pediatr Dermatol; 2019 Mar 01; 36(2):193-199. PubMed ID: 30656753
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tazarotene 0.045% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in Adult Males.
    Cook-Bolden FE, Gold MH, Guenin E.
    J Drugs Dermatol; 2020 Jan 01; 19(1):78-85. PubMed ID: 32023013
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Novel tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris: assessment of safety and tolerability in subgroups.
    Harper JC, Roberts WE, Zeichner JA, Guenin E, Bhatt V, Pillai R.
    J Dermatolog Treat; 2020 Mar 01; 31(2):160-167. PubMed ID: 30935257
    [Abstract] [Full Text] [Related]

  • 12. Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials.
    Tanghetti EA, Werschler WP, Lain T, Guenin E, Martin G, Pillai R.
    J Drugs Dermatol; 2020 Jan 01; 19(1):70-77. PubMed ID: 31985914
    [Abstract] [Full Text] [Related]

  • 13. New Polymeric Once-Daily Tazarotene 0.045% Lotion Formulation for Moderate-to-Severe Acne: Pooled Phase 3 Pediatric Analysis.
    Eichenfield LF, Tanghetti EA, Guenin E, Martin G, Pillai R.
    J Drugs Dermatol; 2020 Jun 01; 19(6):602-610. PubMed ID: 32574011
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris.
    Tanghetti EA, Kircik LH, Green LJ, Guenin E, Harris S, Martin G, Pillai R.
    J Drugs Dermatol; 2019 Jun 01; 18(6):542. PubMed ID: 31251546
    [Abstract] [Full Text] [Related]

  • 16. The Effects of Once-Daily Tretinoin 0.05% Lotion on Quality of Life in Patients with Moderate-to-Severe Acne Vulgaris.
    Tyring SK, Kircik L, Pariser DM, Woolery-Lloyd HC, Harper JC, Bhatt V, Pillai R, Guenin E.
    Am J Clin Dermatol; 2020 Dec 01; 21(6):891-899. PubMed ID: 32886337
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.